Agassi Andre M, Myslicki Francisco A, Shulman Jesse M, Rotterman Yosef, Dosoretz Daniel E, Fernandez Eduardo, Mantz Constantine A, Finkelstein Steven E
21st Century Oncology Translational Research Consortium, 7340 E Thomas Road, Scottsdale, AZ, USA.
Future Oncol. 2014 Dec;10(15):2319-28. doi: 10.2217/fon.14.188.
Radiation therapy and immunotherapy in partnership may have the capability of delivering a therapeutic effect exceeding the sum of its parts. The possible relationship has been demonstrated in murine models and has been extended to a variety of clinical trials. Though the standard notion of whole body radiation therapy is immunosuppressive, there is growing evidence toward the contrary for focal radiation therapy. Furthermore, if immunotherapeutic techniques can retune the immune system against cancerous cells, they should have obvious benefits for advanced treatments moving forward. Herein, we explore the promise in combining radiation therapy and immunotherapy with distinct focus on potential morbidities and toxicities through analysis of completed clinical trials.
放射治疗与免疫治疗相结合可能具有产生超过其各部分之和的治疗效果的能力。这种可能的关系已在小鼠模型中得到证实,并已扩展到各种临床试验中。尽管全身放射治疗的标准概念具有免疫抑制作用,但越来越多的证据表明局部放射治疗的情况恰恰相反。此外,如果免疫治疗技术能够重新调整免疫系统以对抗癌细胞,那么对于未来的晚期治疗应该会有明显的益处。在此,我们通过对已完成的临床试验进行分析,探讨将放射治疗与免疫治疗相结合的前景,特别关注潜在的发病率和毒性。